Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karol Kaltenbach

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Addiction Medicine|July 27, 2017
Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use DisorderMeghan Gannon, Michael Mackenzie, Karol Kaltenbach, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 1, 2018
Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndromeHendrée E Jones, Kevin E O'Grady, Karol Kaltenbach
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 31, 2011
Methadone and the causes of maternal and perinatal complications: a response to Pinto et al. "Substance abuse during pregnancy: effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141]Hendrée E Jones, Karol Kaltenbach, Kevin E O'Grady
Early Human Development|November 15, 2008
The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008, 84, 29-35)Hendrée E Jones, Karol Kaltenbach, Kevin E O'Grady
Journal of Perinatal Medicine|May 22, 2007
Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndromeKevin Dysart, Hui-Chen Hsieh, Karol Kaltenbach, et al.
Neurotoxicology and Teratology|February 19, 2013
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcomeKevin E O'Grady, Hendrée E Jones, Lauren M Jansson, et al.
Neurotoxicology and Teratology|October 9, 2013
The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerationsHendrée E Jones, Lauren M Jansson, Kevin E O'Grady, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysisHeather M Link, Hendree Jones, Lauren Miller, et al.
Journal of Addiction Medicine|January 24, 2020
Letter-in-replyHendrée E Jones, Karol Kaltenbach, Tara Benjamin, et al.
Journal of Addiction Medicine|June 1, 2016
Neonatal Abstinence Syndrome: Presentation and Treatment ConsiderationsHendrée E Jones, Karol Kaltenbach, Elisabeth Johnson, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Addiction Medicine|July 27, 2017
Impact of Mindfulness-Based Parenting on Women in Treatment for Opioid Use DisorderMeghan Gannon, Michael Mackenzie, Karol Kaltenbach, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 1, 2018
Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndromeHendrée E Jones, Kevin E O'Grady, Karol Kaltenbach
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 31, 2011
Methadone and the causes of maternal and perinatal complications: a response to Pinto et al. "Substance abuse during pregnancy: effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141]Hendrée E Jones, Karol Kaltenbach, Kevin E O'Grady
Early Human Development|November 15, 2008
The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008, 84, 29-35)Hendrée E Jones, Karol Kaltenbach, Kevin E O'Grady
Journal of Perinatal Medicine|May 22, 2007
Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndromeKevin Dysart, Hui-Chen Hsieh, Karol Kaltenbach, et al.
Neurotoxicology and Teratology|February 19, 2013
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcomeKevin E O'Grady, Hendrée E Jones, Lauren M Jansson, et al.
Neurotoxicology and Teratology|October 9, 2013
The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerationsHendrée E Jones, Lauren M Jansson, Kevin E O'Grady, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysisHeather M Link, Hendree Jones, Lauren Miller, et al.
Journal of Addiction Medicine|January 24, 2020
Letter-in-replyHendrée E Jones, Karol Kaltenbach, Tara Benjamin, et al.
Journal of Addiction Medicine|June 1, 2016
Neonatal Abstinence Syndrome: Presentation and Treatment ConsiderationsHendrée E Jones, Karol Kaltenbach, Elisabeth Johnson, et al.
Pageof 6